0
Sign In  | Subscribe
18 July 2006, Vol 145, No. 2>
Summaries for Patients | 18 July 2006

Age-Related Macular Degeneration and Stroke FREE

[+] Article and Author Information

The summary below is from the full report titled “Age-Related Macular Degeneration and Risk for Stroke.” It is in the 18 July 2006 issue of Annals of Internal Medicine (volume 145, pages 98-106). The authors are T.Y. Wong, R. Klein, C. Sun, P. Mitchell, D.J. Couper, H. Lai, L.D. Hubbard, and A.R. Sharrett, for the Atherosclerosis Risk in Communities Study.


Ann Intern Med. 2006;145(2):I-37. doi:10.7326/0003-4819-145-2-200607180-00001
Text Size: A A A

What is the problem and what is known about it so far?

Age-related macular degeneration (AMD) is a condition in which the part of the eye called the macula changes as people get older. These changes can result in loss of vision. The disorder is the most common cause of blindness in people older than 40 years of age and affects about 7 million people in the United States. Stroke is a condition in which low blood flow to the brain damages brain tissue. Depending on the size and specific location of the tissue involved, people who have had a stroke can have weakness, uncoordinated movements, and difficulty with speech. In some cases, death may result. The cause of macular degeneration is not well understood but may involve problems with blood flow or inflammation, some of the same problems involved in stroke. A few studies have suggested that people with AMD might be at higher risk for stroke than people without AMD, but these studies have had inconsistent results.

Why did the researchers do this particular study?

To see if people with early-stage AMD are more likely to have a future stroke than people without AMD.

Who was studied?

10,405 people between 49 and 75 years of age and free of stroke or heart disease at the beginning of the study. All of the patients were participating in a large study of risk factors for heart disease that was conducted in 4 U.S. communities in Minnesota, Mississippi, Maryland, and North Carolina. Of note, all of the patients from Mississippi and only 9% of those from North Carolina were African American. All of the patients in Maryland and Minnesota were white.

How was the study done?

At the beginning of the study, all of the patients had special photographs taken of the inside of the eye (retinal photographs). Eye experts reviewed the photographs to determine whether patients had macular degeneration. The researchers then followed patients for up to 10 years to see who had a stroke.

What did the researchers find?

Of the 10,405 patients in the study, 508 had AMD, and 498 of these had early disease at the start of the study. After 10 years, 241 patients in the study had had a stroke. Patients with AMD were more likely to have a stroke than patients who did not have AMD. This association remained even after the researchers accounted for important stroke risk factors, such as age, blood pressure, diabetes, and smoking.

What were the limitations of the study?

The association was not consistent across the 4 study sites. Because no site had sufficient numbers of white and African-American patients, this study is unable to determine whether the differences were associated with ethnicity or some other factor that varied by site.

What are the implications of the study?

People with early-stage AMD appear to be more likely to have a future stroke than people without AMD.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

In the Clinic
Transient Ischemic Attack
Ann Intern Med. 2011;154(1):ITC1-1.
Topic Collections
PubMed Articles
Stroke rates after introduction of vascular endothelial growth factor inhibitors for macular degeneration: a time series analysis.
Ophthalmology Issue date: 2012 Aug
Acute central retinal artery occlusion treated with intravenous recombinant tissue plasminogen activator.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association Issue date: 2012 Nov

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)